The cholesterol-dependent cytolysins (CDCs) are the archetype for the superfamily of oligomeric pore-forming proteins that includes the membrane attack complex/perforin (MACPF) family of immune defense proteins and the stonefish venom toxins (SNTX). The CDC/MACPF/SNTX family exhibits a common protein fold, which forms a membrane-spanning β-barrel pore. We show that changing the relative stability of an extensive intramolecular interface within this fold, which is necessarily disrupted to form the large β-barrel pore, dramatically alters the kinetic and temperature-dependent properties of CDC pore formation. These studies show that the CDCs and other members of the CDC/MACPF/SNTX superfamily have the capacity to significantly alter their pore-forming properties to function under widely different environmental conditions encountered by these species.
KEYWORDS: cold denaturation, complement, gasdermin, perforin, water network
ABSTRACT
The cholesterol-dependent cytolysin (CDC) genes are present in bacterial species that span terrestrial, vertebrate, and invertebrate niches, which suggests that they have evolved to function under widely different environmental conditions. Using a combination of biophysical and crystallographic approaches, we reveal that the relative stability of an intramolecular interface in the archetype CDC perfringolysin O (PFO) plays a central role in regulating its pore-forming properties. The disruption of this interface allows the formation of the membrane spanning β-barrel pore in all CDCs. We show here that the relative strength of the stabilizing forces at this interface directly impacts the energy barrier posed by the transition state for pore formation, as reflected in the Arrhenius activation energy (Ea) for pore formation. This change directly impacts the kinetics and temperature dependence of pore formation. We further show that the interface structure in a CDC from a terrestrial species enables it to function efficiently across a wide range of temperatures by minimizing changes in the strength of the transition state barrier to pore formation. These studies establish a paradigm that CDCs, and possibly other β-barrel pore-forming proteins/toxins, can evolve significantly different pore-forming properties by altering the stability of this transitional interface, which impacts the kinetic parameters and temperature dependence of pore formation.
INTRODUCTION
The study of the pore-forming mechanism of the cholesterol-dependent cytolysins (CDCs) has established paradigms that have served as a basis for understanding the mechanisms of a wide array of pore-forming proteins (1), including the membrane attack complex/perforin-like (MACPF) proteins (2) and the stonefish family of venom toxins (SNTX) (3). These proteins all exhibit an analogous protein fold to domain 3 (D3) of the CDCs, which forms the β-barrel pore (Fig. 1C). The species that produce pore-forming proteins of the CDC/MACPF/SNTX superfamily inhabit a variety of environmental niches where temperatures much lower than 37°C are the norm. For instance, the genes for CDCs are present in bacterial species (e.g., Desulfobulbus propionicus [4] and many species of Paenibacillus [5], Bacillus, and Lysinibacillus) which inhabit terrestrial environments at temperatures (6, 7) where CDCs from human pathogens do not function well (8). Therefore, can the CDC mechanism evolve to adapt to function under much different environmental conditions, especially lower temperatures? We have observed that different CDCs exhibit different kinetics and specific activities of pore formation (4, 9, 10), although the basis for these differences has not been explored.
Recently, we showed that an intermolecular electrostatic interaction was necessary to drive the final stage of the prepore-to-pore transition where two α-helical bundles in domain 3 are refolded and extended into the two transmembrane β-hairpins in each monomer of the oligomeric complex to form the large β-barrel pore (11) (Fig. 1 gives an overview of the perfringolysin O [PFO] pore-forming mechanism). We also showed that a point mutant at the interface between domain 3 and domains 1 and 2 of PFO could restore activity to a mutant wherein the electrostatic interaction had been knocked out (loss of the electrostatic interaction traps PFO in a prepore state). These studies suggested that destabilizing this interface structure eliminated the need for the energy supplied by the electrostatic interaction to drive the prepore-to-pore interaction.
In this study, we reveal that the stability of the D3-D1,2 intramolecular interface directly impacts the activation energy of pore formation by PFO. Decreasing the stability of this interface by a point mutation lowers the activation energy of pore formation, which significantly increases the rate and specific activity of PFO-mediated pore formation, and largely eliminates its loss of pore-forming activity at low temperatures. Crystal structures of PFO and this mutant reveal that this interface in PFO is largely stabilized by a water network and its loss in the mutant destabilizes this interface. We further show that the CDC from the terrestrial bacterium D. propionicus (desulfolysin [DLY] [4]), unlike PFO, exhibits a high level of pore-forming activity across a wide spectrum of temperatures. Our studies suggest that the ability of DLY to function and remain stable at these widely different temperatures is achieved by balancing polar and nonpolar interactions at analogous interfaces. These studies show that decreasing the stability of this interface in the CDCs can significantly change the activation energy of pore formation, which alters the rate and temperature dependence of pore formation. Hence, the CDC pore-forming structure is sufficiently flexible to adapt it to function under widely different environmental conditions. Since the analogous interface is conserved in the CDC/MACPF/SNTX superfamily (3, 12–16), it is likely the fundamental principles learned here can also be applied their pore-forming mechanisms.
RESULTS
Specific activity and temperature dependence of pore formation of various CDCs and their derivatives.
The rate of pore formation at temperatures ranging from 9° to 37°C was determined for CDCs from the human pathogens Clostridium perfringens (PFO) and Streptococcus pneumoniae (PLY) and for the terrestrial bacterium D. propionicus (DLY) (Fig. 2). For PFO and PLY, the rate of pore formation decreased with decreasing temperature, although PLY activity is much more sensitive to temperatures ≤30°C than PFO. In sharp contrast, pore formation by DLY is much less sensitive to lower temperatures: at 15°C DLY exhibits a similar or higher rate of pore formation than PFO and PLY exhibited at 37°C and at 37°C the specific activity of DLY is nearly 4- to 12-fold higher than that of PFO and PLY, respectively. These results show that DLY-mediated pore formation is faster and far less sensitive to temperature than is PLY- and PFO-mediated pore formation.
We previously described a mutant of PFO (N197W) that compensates for the loss of an electrostatic interaction that drives the prepore-to-pore transition (11). This mutation resides within an intramolecular interface between D3 and D1,2 of the PFO monomer (Fig. 1), which needs to be broken to allow the twin α-helical bundles to refold into extended β-hairpins, which form the β-barrel pore (17, 18). When this mutation is placed into native PFO (PFON197W), its pore-forming parameters resemble those of DLY (Fig. 2 and Table 1). These results and our previous results (11) suggest the impact of the N197W mutation on the PFO pore-forming activity results from perturbations within the D3-D1,2 interface.
TABLE 1.
Toxin | % activity | Tm (°C) |
---|---|---|
PFO | 100 | 49.5 |
PFON197W | 380 | 45.3 |
PFOS97G-V98A | 250 | 50.0 |
PFON197C | 50 | 48.5 |
DLY | 360 | 55.9 |
DLYL162G | 100 | 47.0 |
PLY | 28 | 48.9 |
Shown are the relative pore-forming activities of the various CDCs in this study and their melting temperatures (Tm). The pore-forming activity for each CDC and derivatives thereof relative to the pore-forming activity of wild-type PFO was determined from the EC50 of pore formation on carboxyfluorescein-loaded cholesterol-rich liposomes (4) and reported as the percentage of PFO activity at 37°C [% activity = (EC50 PFO/EC50 mutant) × 100]. The results are representative of 3 to 4 experiments.
Structural transitions associated with pore formation are accelerated in PFON197W.
To understand if one or more of the structural transitions necessary for pore formation were affected by the N197W mutation, we used previously established fluorescence-based methods to compare the rate of these transitions to those in PFO.
Membrane binding kinetics of PFO and its derivatives were measured by following the increase in the fluorescence emission of the tryptophans within the conserved undecapeptide, as it enters the membrane upon binding (19). PFON197W binding is ∼4-fold faster than PFO (Fig. 3A). Since this mutation is distal from the binding domain, it does not impact the binding interface structure (as confirmed below in the PFON197W crystal structure); therefore, the initial interaction of the monomers with cholesterol would not be affected. An alternative mechanism to account for the high membrane affinity of PFON197W would be a faster incorporation of monomers into the higher-avidity prepore complex (8), thereby decreasing the off-rate of membrane-bound monomers. This scenario was confirmed by the higher rate of oligomerization for PFON197W than PFO. Oligomerization drives the disengagement of β-strand 5 (β5) from β-strand 4 (β4), which facilitates the formation of stable prepore oligomers (11, 20, 21). Thus, the rate at which β5 disengages can be used to monitor oligomerization. The rate of β5 disengagement was followed by monitoring the change in fluorescence emission of the environmentally sensitive probe NBD attached to V322C, as it makes the transition from a buried location under the α1β5 hairpin (Fig. 4A) in the soluble monomer to a solvent-exposed location in the oligomer where its emission is quenched by water. The disengagement of β5 from β4 is ∼5-fold faster in PFON197W than for PFO (Fig. 3B). Oligomerization rates for PFO and PFON197W (Fig. 3D) were also determined by SDS-agarose gel electrophoresis (SDS-AGE) of samples removed at various times from toxin-liposomes mixtures to assess formation of the oligomer (Fig. 3D). DLY oligomerization was also measured by SDS-AGE as for PFO and PFON197W, which showed it oligomerized faster than PFO (Fig. 3E).
The changes in PFON197W pore-forming properties come at the cost of decreased stability at higher temperatures. Whereas PFO retains full pore-forming activity and oligomer formation on liposomes after being incubated at 45°C prior to the addition of liposomes, PFON197W completely lost the capacity to form oligomers and pores at 45°C (see Fig. S1 in the supplemental material). This is consistent with the reduced thermal stability (see Materials and Methods) of PFON197W (Table 1), which is highly dependent on the D3-D1,2 interface (11).
Upon completion of the prepore complex, the D3-D1,2 interface in each monomer is disrupted to extend ɑ-helical bundle 1, which along with ɑ-helical bundle 2 refolds into transmembrane β-hairpin 1 and transmembrane β-hairpin 2, respectively, to form the β-barrel pore (Fig. 1) (17, 18). The insertion of the β-barrel, as measured by the increase in the fluorescence emission of NBD-labeled A215C in transmembrane β-hairpin 1, as it transitions from a polar environment in the soluble monomer to the nonpolar environment of the membrane (18), was ∼6-fold faster in PFON197W than PFO (Fig. 3C). Hence, all measurable transitions, from binding to the insertion of the β-barrel pore, were accelerated in PFON197W.
Crystal structures of PFON197W and DLY.
To gain insight into the structural basis for the differences in pore-forming activity of PFO versus that of PFON197W and DLY, we solved the crystal structures for the latter two proteins (Fig. 4A). Two crystal forms for PFON197W were generated: one diffracted to 3.3-Å resolution (PFON197Wlow) and the other diffracted to 2.7-Å resolution (PFON197Whigh) (Table S1). The electron density maps of PFON197Whigh were of sufficient quality to identify 101 water molecules. Most of the following analyses focus on comparison of the wild-type structure of PFO (22) and that of DLY with PFON197Whigh, but we have also compared them to the PFON197Wlow structure, where differences with native PFO might be due to crystal lattice effects.
DLY was crystallized, and its structure was determined by multiple anomalous dispersion to a resolution of 2.3 Å (Table S1). Despite the relatively low sequence homology between DLY and CDCs from Gram-positive bacteria (∼40% identity with PFO) with known crystal structures, DLY adopts a similar overall shape, topology, and domain arrangement (Fig. 4A). Most CDCs have just one cysteine residue, which is located in the undecapeptide motif, whereas DLY has three additional cysteine residues (C54 in D2 and C166 and C266 in D3), none of which are in a disulfide, although C166 could not be altered without decreasing pore-forming activity (E. M. Hotze and R. K. Tweten, unpublished data; also reference 4).
PFON197W and DLY D3-D1,2 interface structures.
The oligomerization and assembly of the membrane-spanning β-barrel pore require the twist in the D3 core β-sheet to be relieved (Fig. 1) to pair β-strands 1 and 4 between two monomers (20). The next step is that the D3-D1,2 interface of each monomer in the completed prepore needs to be disrupted to refold and extend αHB1 into one of the two transmembrane β-hairpins to form the large β-barrel pore (Fig. 1) (17, 18). In PFO, the majority of the interactions at this interface in the soluble monomer are mediated by an extensive water network (23), which is largely missing in the vicinity of N197W (Fig. 4 and Fig. S2), although care must be taken in comparing the fine detail of the two structures given their different resolutions. The bulkier side chain of the tryptophan residue clearly displaces two waters observed in PFO (waters 584 and 756 using 1PFO numbering), and the movement of the side chain of N377 displaces water 704 (Fig. S2). Loss of these three waters is expected to disrupt the local H-bonding network around N197W. In PFO, N197 forms hydrogen bonds (H-bonds) with waters 657 and 795. The former water is not in H-bonding distance of any other waters but is close to water 683 (3.3 Å). The latter water is within H-bonding distance of waters 704 (lost by the movement of N377 in the mutant) and 756 (a water displaced by the mutation). Thus, in PFON197W this water has lost all its H-bonding partners observed in PFO, which provides an explanation for its absence in the mutant.
To overcome the uncertainty resulting from the difference in resolution of the crystallographic structures of PFO and PFON197W and the consequent reduction in visible waters in PFON197W, we carried out molecular dynamics (MD) simulations to explore differences in the dynamic behavior of the D3-D1,2 interface. The stability of water molecules around residue 197 was determined by creating a solvent residence map across the simulation of each protein (24). The stable solvent includes several of the crystallographic waters seen in PFO. There are two regions of stable solvent in the PFO simulation capping the C-terminal end of the D3 helix (residues 188 to 197) at residues 194 and 195 that are directly disrupted in PFON197W, with the tryptophan displacing all solvent in this volume (Fig. S3A). Its side chain also disrupts the stable water volume associated with the backbone of residue 196 through hydrophobic effects. This alteration in the solvation cap around the C-terminal end of the helix is consistent with a loss of stability around residue 197.
The simulations also revealed a stable water chain reaching from the side chain of N197 to a position between the backbone carbonyl oxygens of S93 and L114, corresponding to crystallographic waters 683, 581, and 637 in 1PFO. This chain is broken in the simulations of PFON197W, with no equivalent stable waters (Fig. S3B). The presence of the stable water chain in PFO and its absence in PFON197W are consistent with the dependence of the D96-Y103 interaction with the β4-β5 loop glycine pair (G324, G325) on water-mediated interactions in this region.
The D3-D1,2 interface in DLY differs substantially from that in PFO. There are fewer than half as many D3-D1,2 interfacial water molecules identifiable in the crystal structure of DLY, compared to PFO (15 and 37, respectively), which can be attributed, in part, to the greater number of bulky nonpolar residues that result in a more tightly packed interface that excludes solvent. In DLY, 49% of the interfacial residues are nonpolar compared to 38% in PFO, and to a large extent, the nonpolar residues in PFO are not in complementary interactions (i.e., hydrophobic-hydrophobic) (22), whereas they are in DLY. Consequently, there is a greatly reduced number of hydrogen bonding interactions present across the interface, with 12 protein-to-protein H-bonds in PFO compared to only 6 in DLY. Bridging waters (which form H-bonds with residues in both D3 and D1,2) are also reduced from 12 in PFO to 7 in DLY.
The only significant deviation between the PFO and PFON197W is a loop that is displaced 7 Å in the latter and encompasses D1 residues D96 to Y103 (Fig. 4B). This difference partially results from contacts with the N-terminal helix of a symmetry-related molecule in the crystal lattice of both mutant structures, which are not seen in PFO. However, other PFO crystal structures (23) exhibit a similar packing arrangement in this region but do not show the displacement of this loop, which strongly suggests that the loop is specifically displaced in PFON197W independently of the crystal contacts. Interestingly, the analogous loop in native DLY (S66 to P74) adopts a conformation similar to that observed in PFON197W where it does not contact the glycine pair analogue (G296, G297) in DLY (Fig. 4B). The glycine pair is a flexible linker region that allows the rotation of β5 away from β4, which allows the subsequent edge-on pairing of β4 of one monomer with β1 of another monomer during their oligomerization (20). These results suggest that the conformational differences in the D3-D1,2 interface between PFO and that of DLY and PFON197W contribute to the difference in the activity and the sensitivity of pore formation to low temperatures.
We mimicked the loss of the contact of the D96 to Y103 loop with the loop containing the conserved glycine pair by removing the S97 and V98 side chains in PFOS97G-V98A. Its specific activity (Table 1) and rate of pore formation (Fig. 2B) increased, but it did not alter the temperature dependence of pore formation (Fig. 2A), consistent with the similarity of its melting temperature (Tm) to that of PFO (Table 1). The rate of β5 disengagement from β4, which reflects the rate of oligomerization of the monomers into the prepore (20), was only slightly higher than PFO (Fig. 3F). These results suggest the primary impact of rotating this loop away from the glycine pair is to increase the rate of the prepore-to-the-pore transition, which suggests that it is a necessary conformational change for the step in pore formation wherein the prepore is converted to the pore. The mutation, however, had no discernible effect on the temperature dependence of pore formation. Hence, the stability of the D3-D1,2 interface is the major factor affecting the temperatures dependence of PFO.
Chemical modification of the PFON197C sulfhydryl triggers its transition to the pore at low temperature.
Like PFO (8), low temperature significantly slows the conversion of the PFON197C prepore to the pore, although it converts to a pore state at a slightly higher rate than PFO. This suggests that the water network is largely intact in the D3-D1,2 interface of PFON197C, which is consistent with the similarity of its Tm (48.5°C) to that of PFO (49.5°C). When PFON197C was allowed to first assemble into a prepore at low temperature, its transition to the pore could be rapidly triggered by the injection of N-ethylmaleimide (NEM), a small hydrophobic compound that modifies cysteine thiols (Fig. 5), whereas NEM had no effect on native PFO. PFON197C labeled with NEM prior to its injection exhibited similar pore-forming activity at low temperature (Fig. 5B), but the rate was slightly lower than that observed in Fig. 5A, where it was first allowed to form the prepore for the addition of the NEM. Therefore, the water network in PFON197C still maintained the prepore state until NEM modified the N197C thiol. Hence, the modification of the thiol with NEM likely mimics the effect of the substitution of tryptophan for N197 by displacing the stabilizing water network at the D3-D1,2 interface, which can be effectively accomplished before or after prepore assembly.
Arrhenius activation energy of pore formation.
We next examined the Arrhenius activation energies (Ea) of pore formation by the various CDCs and derivatives (Fig. 6). Since PFON197W presumably lost most of its D3-D1,2-stabilizing water network, we hypothesized that its Ea would decrease substantially, thereby explaining the increased rate of pore formation and activity at low temperature. The initial velocities of pore formation by each toxin were measured across a range of temperatures, and this information was then used to calculate the Ea. Consistent with the above hypothesis, PFON197W exhibited an Ea of 17 kcal/mol, which is ∼10 kcal/mol lower than that for PFO and DLY (∼27 kcal/mol each). PLY exhibits a significantly higher Ea (77 kcal/mol) than both PFO and DLY, which correlates with weak pore-forming activity at temperatures below 37°C (Fig. 2A).
These data suggest that the loss of the D3-D1,2-stabilizing water network in PFON197W reduces its thermal stability, lowers its Ea for pore formation, and increases the specific activity of pore formation and pore formation at lower temperatures. These improved pore-forming parameters in PFON197W, however, come at a cost: They reduce protein stability at higher temperatures. The fact that DLY exhibits the same Ea as PFO but has a higher thermal stability suggests that DLY has evolved a different way to function at low temperature while remaining stable at higher temperatures.
The DLY D3-D1,2 residue L162 side chain-mediated interactions impact its pore-forming activity and temperature dependence of pore formation.
DLY has a 6°C-higher Tm than PFO (Table 1), suggesting that its D3-D1,2 interface is more stable than that of PFO, yet it functions much better at low temperature than PFO (Fig. 2). One significant difference in the D3-D1,2 interface with that of PFO is the presence of a strong nonpolar interaction between the side chain of L162 in αHB1 (which refolds into transmembrane β-hairpin 1) and a hydrophobic core of D2 residues consisting of F25, Y56, A58, and F60 (Fig. 7). When L162 was changed to a glycine, its Tm dropped nearly 9°C (Table 1), showing that it is a major contributor to the stability of the D3-D1,2 interface. The specific activity of DLYL162G decreased nearly 4-fold, consistent with its higher Ea of its pore formation of 42 kcal/mol (Fig. 6), compared to DLY. The impact of weakening the D3-D1,2 interface on the specific activity of DLY and temperature dependence of pore formation was surprising compared to PFON197W, which exhibited enhanced pore-forming activity across the temperature spectrum. These results suggest that the L162-mediated nonpolar interactions with D2 residues positively impact its activity at the low and high end of the temperature range.
DISCUSSION
The studies here show that the relative stability of the D3-D1,2 interface has a major impact on the transition state for pore formation by PFO. The stability of this interface affects the Ea of pore formation, which impacts all stages of the pore-forming mechanism. All CDCs have the analogous interface structure; thus, the relative stability of this interface impacts the pore-forming activity of all CDCs. In PFO, this interface is primarily stabilized by a network of water-mediated H bonds, and its disruption in PFON197W dramatically improves the pore-forming properties of PFO and largely eliminates its loss of activity at low temperatures where it is normally trapped in a prepore complex (8). Native DLY exhibits similar pore-forming properties as PFON197W, which is consistent with the adaptation of the DLY structure and mechanism to function under the wide range of temperatures which are encountered by D. propionicus in its terrestrial niches. The studies here, however, suggest that DLY has evolved a different D3-D1,2 structure to maintain a high level of pore-forming activity and stability over a broad range of temperatures. Rather than being dominated by an H-bonded water-stabilized interface like PFO, the DLY D3-D1,2 interface is stabilized by a mix of polar and nonpolar interactions. Polar and nonpolar interactions weaken and strengthen inversely with temperature, which would tend to minimize changes in the strength of the interactions that stabilize the DLY D3-D1,2 interface across a wider range of temperatures. This would minimize changes in the strength of the transition state for pore formation, thereby ensuring that DLY remained active and stable across a wider range of temperatures.
The crystal structure of PFON197W and MD simulations show that the water network throughout the D3-D1,2 interface of PFO is largely disrupted, consistent with its lower Tm. The weakened D3-D1,2 interface lowers the Ea for pore formation, which results in faster kinetics of prepore assembly and conversion to the pore and alleviates the loss of activity at lower temperatures. This scenario is further supported by the experiments with PFON197C wherein the low-temperature-trapped prepore could be triggered to rapidly convert to the pore by the NEM modification of the cysteine thiol. The hydrophobic nature of NEM likely disrupted the water network by the steric/hydrophobic displacement of the waters in a manner similar to that of the hydrophobic side chain of tryptophan in PFON197W. Hence, in PFO as the temperature decreases, the water-mediated H bonds at this interface increase in strength, which effectively increases the energy barrier of the transition state to a point where the forces normally driving this change are no longer sufficient. The loss of the water network in PFON197W effectively diminishes these stabilizing forces at the D3-D1,2 interface. Therefore, the forces that drive the assembly of the pore remain sufficient to overcome the transition state at the lower temperatures.
In contrast to PFO, DLY exhibits significant pore-forming activity between 15 and 37°C, yet it exhibits a significantly higher Tm than PFO (∼6°C) and the same Ea. The higher Tm is consistent with the presence of more nonpolar interactions at its D3-D1,2 interface, which increase in strength with increasing temperature (25). L162 mediates a major nonpolar interaction between D3 and D2 (Fig. 7). Although the rate of pore formation by DLYL162G increased with temperature, it released less total CF marker below 20°C and above 25°C than DLY, but at 20 to 25°C total marker release was similar to DLY. At lower temperatures, nonpolar interactions weaken with decreasing temperature and have been shown to be responsible for cold denaturation of proteins at temperatures above 0°C in the absence of denaturants (26–29). Hence, at lower temperatures it is possible that the destabilizing effect of this nonpolar interaction is lost in DLYL162G, which would make it more difficult to disrupt its domain 3-domain 1,2 interface and convert to the pore. Above 25°C, the loss of the L162-mediated hydrophobic interactions would result in a less stable D3-D1,2 interface, which is consistent with its lower Tm and may lead to the premature unfolding and inactivation of DLY monomers. Therefore, we suggest that in native DLY the opposing effects of the polar and nonpolar interactions with temperature would minimize changes in the overall stability of the D3-D1,2 interface, which allows the forces driving this transition to be adequate across a broad range of temperatures.
Collectively, these data show that the loss of the water network that stabilizes the D3-D1,2 interface in PFO has far-reaching effects on all aspects of its pore-forming mechanism. The increased rate of oligomerization suggests that the weakened D3-D1,2 interface must facilitate early conformational changes necessary for the stable interaction of membrane-bound monomers. The increased rate of monomer incorporation into the higher-avidity prepore complexes effectively decreases the monomer off-rate from the membrane, which lowers the EC50 of pore formation. The disruption of the S97-V98 loop interaction with the G324-G325-containing loop contributes to the increased rate of pore formation but not the temperature dependence of PFO. The network of water-mediated H bonds at the D3-D1,2 interface in PFO is the dominant factor responsible for the loss of pore-forming activity as the temperature decreases. In contrast to PFO, DLY has evolved a different solution to function and remain stable across a wide range of temperatures by including a combination of both polar and nonpolar interactions at its D3-D1,2 interface. Finally, PFON197W demonstrates that the CDC pore-forming mechanism is capable of maintaining high activity down to 6°C, and probably lower. This shows that the CDC structure can evolve to function well at extremely low temperatures, which may be necessary for CDC-expressing species that are found in terrestrial habitats where temperatures remain near freezing much of the year (6, 7).
The temperature dependence of the CDCs here reflects the lifestyles of the bacterial species. D. propionicus exhibits growth across a broad range of temperatures (10 to 40°C) (30), which correlates with the temperature range at which DLY retains significant activity. C. perfringens is present in terrestrial environments and intestinal tracts of humans and animals; however, its growth decreases rapidly at temperatures of ≤30°C (31, 32), which corresponds to the temperature dependence of PFO pore-forming activity. In contrast to PFO and DLY, PLY pore formation is most efficient at 37°C and drops off rapidly below 37°C, which is consistent with its evolution as a human commensal. PLY is unusual in that it appears to be secreted by an unknown mechanism and is retained for long periods within the cell wall of S. pneumoniae (33). In its commensal state, the higher Ea may minimize the possible activation of PLY (even in the absence of cholesterol) where it could damage the bacterial cell.
These studies show that the evolution of the D3-D1,2 interface structure can endow the CDCs with significantly different pore-forming properties. The modulation of these properties likely accommodates the requirements of the myriad species that utilize CDCs to establish and/or maintain their presence in their respective niches.
MATERIALS AND METHODS
Mutagenesis, expression, and purification of PFO, DLY, and their derivatives.
In vitro mutagenesis of the codon-optimized DLY and PFO genes, their expression, and purification of the recombinant proteins and derivatives from Escherichia coli Tuner were carried out as previously described (11, 18). The cysteine-less derivative of PFO (PFOC459A) is referred to here as PFO. All proteins and chemically modified proteins were centrifuged (14,000 × g for 10 min at 4°C) to remove any precipitated protein and assayed for concentration before use as described previously (10). Selenomethionine derivatives of DLY were obtained by expression using the selenomethionine kit from Molecular Dimensions (USA), according to the manufacturer’s instructions.
Liposome preparation.
Liposomes that contained a 45:55 mol% ratio of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids) to cholesterol (Sigma-Aldrich) were prepared as described previously (18). The same liposomes with encapsulated 5(6)-carboxyfluorescein (CF) (Sigma) were prepared as described previously (4).
Carboxyfluorescein-liposome release assay for the EC50 analysis.
The EC50, which is the effective concentration of toxin required to release 50% of the encapsulated CF from liposomes, was measured and calculated as described previously (4).
Modification of PFO with fluorescent probes.
PFO derivatives with a cysteine residue substituted at various positions were modified via the sulfhydryl group with the sulfhydryl-specific fluorescent dyes IANBD [N,N′-dimethyl-N-(iodoacetyl)-N′-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine], Alexa Fluor 488 C5 maleimide, and tetramethylrhodamine-5-maleimide (ThermoFisher), as previously described (20).
SDS-agarose gel electrophoresis (SDS-AGE).
Oligomer formation by PFO and its derivatives was determined by SDS-AGE as previously described (8).
PFO, DLY, and derivative melting temperatures.
The Tm was determined as previously described (11). Briefly, the Tm of the proteins was determined using a 7500 Fast real-time PCR system to generate the thermal gradient. Unfolding of the proteins was detected using the Protein Thermal Shift Dye kit (Applied Biosystems) according to the manufacturer’s protocol wherein the fluorescent dye binds to exposed hydrophobic regions of the proteins as it unfolds. The Tm represents the temperature at which 50% unfolding is detected.
Fluorescence spectroscopic methods.
All fluorescence measurements (except for the Tm determination) were performed on a Fluorolog-3-Spectrofluorometer with FluorEssence software (Horiba Jobin Yvon) or on an SLM 8100 fluorimeter. The excitation and emission wavelengths for 5(6)-carboxyfluorescein (CF), NBD, and tryptophan were 480 and 520 nm, 478 and 530 nm, and 280 and 340 nm, respectively.
The kinetics of pore formation by PFO and its derivatives were determined by using CF-loaded liposomes as described previously (11). The fluorescence emission of CF concentrated in the liposomes is quenched, and upon pore formation, the release of the CF results in dequenching of its emission due to dilution. The emission increase as the CF was released was monitored over time.
The kinetics of PFO and PFON197W binding to liposome membranes were measured by following the emission of the 3 tryptophans in the undecapeptide (UDP), which insert into the membrane upon binding (19). Upon membrane binding, the UDP tryptophans transition from the polar environment in the soluble monomer and partition into the nonpolar environment of the bilayer, which results in the increase of their emission at 340 nm, as they are no longer quenched by water.
The kinetics of β-barrel insertion were determined as previously described (19). Residue A215 was substituted with cysteine in PFO and PFON197W. A215 partitions its side chain into the bilayer upon formation of the β-barrel pore and has been used extensively by us to monitor the kinetics of β-barrel insertion. The A215C was modified with the environmentally sensitive probe N,N′-dimethyl-N-(iodoacetyl)-N′-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine (IANBD, or NBD here). Upon the transition from the polar environment of the soluble PFO monomer, wherein water quenches the emission of the NBD, to the insertion of the β-barrel pore, the NBD emission increases due to the exclusion of water.
To measure the oligomerization of PFO or PFON197W, each was substituted with V322C, which was then labeled with NBD. Upon oligomerization, V322 undergoes a nonpolar-to-polar transition (measured as a decrease in the emission of NBD) as the α1β5 loop rotates away from β4, thereby exposing the edge of β4 (20). The exposure of β4 of one monomer then allows it to pair and form backbone H bonds with β1 of another monomer during oligomerization of the prepore.
For the membrane insertion and oligomerization assays, self-quenching of the NBD due to proximity in the oligomer was minimized by mixing a 1:2 ratio of NBD-labeled protein with unlabeled protein. For the membrane binding, membrane insertion, and oligomerization assays, the final concentration of toxin was 7 nM in a 2-ml volume containing 20 μl of liposomes from a stock prepared as described above. Toxin was injected (50 μl) into the cuvette (2 ml HEPES-buffered saline [HBS] containing 20 μl liposomes) at 30 s, and the emission was followed over time.
Arrhenius energy of activation (Ea) determination.
The Ea for CDC-mediated pore formation was calculated as described previously (11). The initial velocities of pore formation at various temperatures were determined in quadruplicate and used to calculate the Ea for PFO, DLY, PLY, and their derivatives. Initial velocities were derived from the linear portion of the CF release curve. Each cuvette contained 2 ml HBS (20 mM HEPES-buffered saline, pH 7.4) into which 50 μl of each CDC was injected to a final concentration of 37 nM for PFO, 56 nM for PLY, and 3.7nM for DLY and PFON197W (due to the difference in specific activities of each toxin). Temperature was controlled using a recirculating chiller that maintained the fluorimeter cuvette turret at the selected temperature.
Crystallization of PFON197W and DLY.
Crystals were obtained from PFON197W (5 mg/ml) using the hanging drop method with precipitant of 9% (wt/wt) PEG 6000, 100 mM HEPES, pH 7.0, and 2% (vol/vol) dioxane at 21°C. Crystals of DLY (2.6 mg/ml, 20 mM Tris, pH 7.2, 500 mM NaCl, 5 mM DTT) were obtained by mixing with an equal volume of precipitant consisting of 12 to 14% PEG 6000, 10% Tacsimate, pH 5, at 21°C.
Structure determination.
Diffraction data were collected on the MX beamlines at the Australian Synchrotron (Clayton, Australia), at 100 K using Blue-Ice (34) and processed with XDS (35). For PFON197W structure determination, molecular replacement was performed using MOLREP (36) with 1PFO (22, 23). Diffraction data were acquired from DLY crystals containing selenomethionine residues. Experimental phases were determined using the MAD method with AutoRickshaw (37, 38). The data and refinement statistics are given in Table S1 in the supplemental material.
MD simulations.
Models derived from the PFON197high structure and the PFO structure (1PFO) were prepared. Each model was solvated and ionized to be electrically neutral with 0.15 M NaCl. Periodic boundary conditions were employed to restrict the simulation to 132 Å by 64 Å by 72 Å with a total of 16,670 TIP3P (transferable intermolecular potential with 3 points) water molecules and 50 Na+ and 47 Cl− ions. The total number of atoms in the simulation was 57,367 for PFO and 57,377 for PFON197W. Initial equilibration and simulation were carried out using NAMD (39) on BlueGene/Q architecture for 30-ns simulation with an NPT ensemble (constant number of particles, constant pressure, and constant temperature) at 310 K maintained with a Langevin thermostat. Long-range coulomb forces were computed with the Particle Mesh Ewald method with a grid spacing of 1 Å. Two-femtosecond time steps were used with nonbonded interactions calculated every 2 fs and full electrostatics every 4 fs while hydrogens were constrained with the SHAKE algorithm. The cutoff distance was 12 Å with a switching distance of 10 Å and a pair-list distance of 14 Å. Pressure was controlled to 1 atmosphere using the Nosé-Hoover-Langevin piston method employing a piston 316 period of 100 fs and a piston decay of 50 fs. Trajectory frames were captured every 100 picoseconds. MD trajectories were analyzed and water maps were calculated using VMD (24).
Accession numbers.
The structures have been deposited in the Protein Data Bank (http://www.rcsb.org/pdb/) under the accession numbers 5DHL and 5DIM for PFON197Whigh and PFON197Wlow, respectively, and 6NAL for DLY.
ACKNOWLEDGMENTS
This work was supported by the National Institutes of Health (NIAID) (R37-AI037657 to R.K.T.). An Australian Research Council Discovery Grant (DP160101874) to M.W.P. supported the structural studies. MD simulations were supported by a grant from the Victorian Life Sciences Computation Initiative (VR0021) on its Peak Computing Facility (University of Melbourne), an initiative of the Victorian Government and by resources provided by the Pawsey Supercomputing Centre with funding from the Australian Government and the Government of Western Australia. Funding from the Victorian Government Operational Infrastructure Support Scheme to St Vincent’s Institute is acknowledged. M.W.P. is a National Health and Medical Research Council of Australia Research Fellow.
Work was partly performed on the MX1 and MX2 beamlines at the Australian Synchrotron and made use of the ACRF detector. We thank the beamline staff for their assistance. The technical assistance of P. Parrish is appreciated.
K.R.W., S.L.L., and A.J.F. designed and performed experiments, data analysis, and manuscript preparation. E.M.H., M.J.K., M.A.G., M.P.C., and S.P. designed and performed experiments. C.J.M. performed experiments and data analysis and contributed to manuscript preparation. M.W.P. performed data analysis and contributed to manuscript preparation. R.K.T. designed and performed experiments, analyzed data, and contributed to manuscript preparation.
We declare that we have no competing interests.
Footnotes
Citation Wade KR, Lawrence SL, Farrand AJ, Hotze EM, Kuiper MJ, Gorman MA, Christie MP, Panjikar S, Morton CJ, Parker MW, Tweten RK. 2019. The structural basis for a transition state that regulates pore formation in a bacterial toxin. mBio 10:e00538-19. https://doi.org/10.1128/mBio.00538-19.
Contributor Information
Eric A. Johnson, University of Wisconsin-Madison.
Bruce McClane, University of Pittsburgh School of Medicine.
Michael Niederweis, University of Alabama at Birmingham.
REFERENCES
- 1.Tweten RK, Hotze EM, Wade KR. 2015. The unique molecular choreography of giant pore formation by the cholesterol-dependent cytolysins of gram-positive bacteria. Annu Rev Microbiol 69:323–340. doi: 10.1146/annurev-micro-091014-104233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Dunstone MA, Tweten RK. 2012. Packing a punch: the mechanism of pore formation by cholesterol dependent cytolysins and membrane attack complex/perforin-like proteins. Curr Opin Struct Biol 22:342–349. doi: 10.1016/j.sbi.2012.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ellisdon AM, Reboul CF, Panjikar S, Huynh K, Oellig CA, Winter KL, Dunstone MA, Hodgson WC, Seymour J, Dearden PK, Tweten RK, Whisstock JC, McGowan S. 2015. Stonefish toxin defines an ancient branch of the perforin-like superfamily. Proc Natl Acad Sci U S A 112:15360–15365. doi: 10.1073/pnas.1507622112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hotze EM, Le HM, Sieber JR, Bruxvoort C, McInerney MJ, Tweten RK. 2013. Identification and characterization of the first cholesterol-dependent cytolysins from Gram-negative bacteria. Infect Immun 81:216–225. doi: 10.1128/IAI.00927-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Grady EN, MacDonald J, Liu L, Richman A, Yuan ZC. 2016. Current knowledge and perspectives of Paenibacillus: a review. Microb Cell Fact 15:203. doi: 10.1186/s12934-016-0603-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Reddy GS, Uttam A, Shivaji S. 2008. Bacillus cecembensis sp. nov., isolated from the Pindari glacier of the Indian Himalayas. Int J Syst Evol Microbiol 58:2330–2335. doi: 10.1099/ijs.0.65515-0. [DOI] [PubMed] [Google Scholar]
- 7.Kishore KH, Begum Z, Pathan AA, Shivaji S. 2010. Paenibacillus glacialis sp. nov., isolated from the Kafni glacier of the Himalayas, India. Int J Syst Evol Microbiol 60:1909–1913. doi: 10.1099/ijs.0.015271-0. [DOI] [PubMed] [Google Scholar]
- 8.Shepard LA, Shatursky O, Johnson AE, Tweten RK. 2000. The mechanism of assembly and insertion of the membrane complex of the cholesterol-dependent cytolysin perfringolysin O: formation of a large prepore complex. Biochemistry 39:10284–10293. doi: 10.1021/bi000436r. [DOI] [PubMed] [Google Scholar]
- 9.Farrand S, Hotze E, Friese P, Hollingshead SK, Smith DF, Cummings RD, Dale GL, Tweten RK. 2008. Characterization of a streptococcal cholesterol-dependent cytolysin with a Lewis y and b specific lectin domain. Biochemistry 47:7097–7107. doi: 10.1021/bi8005835. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wade KR, Hotze EM, Briles DE, Tweten RK. 2014. Mouse, but not human, ApoB-100 lipoprotein cholesterol is a potent innate inhibitor of Streptococcus pneumoniae pneumolysin. PLoS Pathog 10:e1004353. doi: 10.1371/journal.ppat.1004353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wade KR, Hotze EM, Kuiper MJ, Morton CJ, Parker MW, Tweten RK. 2015. An intermolecular electrostatic interaction controls the prepore-to-pore transition in a cholesterol-dependent cytolysin. Proc Natl Acad Sci U S A 112:2204–2209. doi: 10.1073/pnas.1423754112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Hadders MA, Beringer DX, Gros P. 2007. Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense. Science 317:1552–1554. doi: 10.1126/science.1147103. [DOI] [PubMed] [Google Scholar]
- 13.Rosado CJ, Buckle AM, Law RH, Butcher RE, Kan WT, Bird CH, Ung K, Browne KA, Baran K, Bashtannyk-Puhalovich TA, Faux NG, Wong W, Porter CJ, Pike RN, Ellisdon AM, Pearce MC, Bottomley SP, Emsley J, Smith AI, Rossjohn J, Hartland EL, Voskoboinik I, Trapani JA, Bird PI, Dunstone MA, Whisstock JC. 2007. A common fold mediates vertebrate defense and bacterial attack. Science 317:1548–1551. doi: 10.1126/science.1144706. [DOI] [PubMed] [Google Scholar]
- 14.Slade DJ, Lovelace LL, Chruszcz M, Minor W, Lebioda L, Sodetz JM. 2008. Crystal structure of the MACPF domain of human complement protein C8 alpha in complex with the C8 gamma subunit. J Mol Biol 379:331–342. doi: 10.1016/j.jmb.2008.03.061. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Law RHP, Lukoyanova N, Voskoboinik I, Caradoc-Davies TT, Baran K, Dunstone MA, D’Angelo ME, Orlova EV, Coulibaly F, Verschoor S, Browne KA, Ciccone A, Kuiper MJ, Bird PI, Trapani JA, Saibil HR, Whisstock JC. 2010. The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 468:447–451. doi: 10.1038/nature09518. [DOI] [PubMed] [Google Scholar]
- 16.Xu Q, Abdubek P, Astakhova T, Axelrod HL, Bakolitsa C, Cai X, Carlton D, Chen C, Chiu HJ, Clayton T, Das D, Deller MC, Duan L, Ellrott K, Farr CL, Feuerhelm J, Grant JC, Grzechnik A, Han GW, Jaroszewski L, Jin KK, Klock HE, Knuth MW, Kozbial P, Krishna SS, Kumar A, Lam WW, Marciano D, Miller MD, Morse AT, Nigoghossian E, Nopakun A, Okach L, Puckett C, Reyes R, Tien HJ, Trame CB, van den Bedem H, Weekes D, Wooten T, Yeh A, Zhou J, Hodgson KO, Wooley J, Elsliger MA, Deacon AM, Godzik A, Lesley SA, Wilson IA. 2010. Structure of a membrane-attack complex/perforin (MACPF) family protein from the human gut symbiont Bacteroides thetaiotaomicron. Acta Crystallogr Sect F Struct Biol Cryst Commun 66:1297–1305. doi: 10.1107/S1744309110023055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Shatursky O, Heuck AP, Shepard LA, Rossjohn J, Parker MW, Johnson AE, Tweten RK. 1999. The mechanism of membrane insertion for a cholesterol-dependent cytolysin: a novel paradigm for pore-forming toxins. Cell 99:293–299. doi: 10.1016/S0092-8674(00)81660-8. [DOI] [PubMed] [Google Scholar]
- 18.Shepard LA, Heuck AP, Hamman BD, Rossjohn J, Parker MW, Ryan KR, Johnson AE, Tweten RK. 1998. Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an α-helical to β-sheet transition identified by fluorescence spectroscopy. Biochemistry 37:14563–14574. doi: 10.1021/bi981452f. [DOI] [PubMed] [Google Scholar]
- 19.Heuck AP, Hotze E, Tweten RK, Johnson AE. 2000. Mechanism of membrane insertion of a multimeric b-barrel protein: perfringolysin O creates a pore using ordered and coupled conformational changes. Mol Cell 6:1233–1242. doi: 10.1016/S1097-2765(00)00119-2. [DOI] [PubMed] [Google Scholar]
- 20.Ramachandran R, Tweten RK, Johnson AE. 2004. Membrane-dependent conformational changes initiate cholesterol-dependent cytolysin oligomerization and intersubunit beta-strand alignment. Nat Struct Mol Biol 11:697–705. doi: 10.1038/nsmb793. [DOI] [PubMed] [Google Scholar]
- 21.Hotze EM, Wilson-Kubalek E, Farrand AJ, Bentsen L, Parker MW, Johnson AE, Tweten RK. 2012. Monomer-monomer interactions propagate structural transitions necessary for pore formation by the cholesterol-dependent cytolysins. J Biol Chem 287:24534–24543. doi: 10.1074/jbc.M112.380139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Rossjohn J, Feil SC, McKinstry WJ, Tweten RK, Parker MW. 1997. Structure of a cholesterol-binding thiol-activated cytolysin and a model of its membrane form. Cell 89:685–692. doi: 10.1016/S0092-8674(00)80251-2. [DOI] [PubMed] [Google Scholar]
- 23.Rossjohn J, Polekhina G, Feil SC, Morton CJ, Tweten RK, Parker MW. 2007. Structures of perfringolysin O suggest a pathway for activation of cholesterol-dependent cytolysins. J Mol Biol 367:1227–1236. doi: 10.1016/j.jmb.2007.01.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Humphrey W, Dalke A, Schulten K. 1996. VMD: visual molecular dynamics. J Mol Graph 14:33–38. doi: 10.1016/0263-7855(96)00018-5. [DOI] [PubMed] [Google Scholar]
- 25.Schellman JA. 1997. Temperature, stability, and the hydrophobic interaction. Biophys J 73:2960–2964. doi: 10.1016/S0006-3495(97)78324-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Pastore A, Martin SR, Politou A, Kondapalli KC, Stemmler T, Temussi PA. 2007. Unbiased cold denaturation: low- and high-temperature unfolding of yeast frataxin under physiological conditions. J Am Chem Soc 129:5374–5375. doi: 10.1021/ja0714538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Privalov PL. 1990. Cold denaturation of proteins. Crit Rev Biochem Mol Biol 25:281–305. doi: 10.3109/10409239009090613. [DOI] [PubMed] [Google Scholar]
- 28.Sanfelice D, Morandi E, Pastore A, Niccolai N, Temussi PA. 2015. Cold denaturation unveiled: molecular mechanism of the asymmetric unfolding of yeast frataxin. Chemphyschem 16:3599–3602. doi: 10.1002/cphc.201500765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Dias CL, Ala-Nissila T, Wong-Ekkabut J, Vattulainen I, Grant M, Karttunen M. 2010. The hydrophobic effect and its role in cold denaturation. Cryobiology 60:91–99. doi: 10.1016/j.cryobiol.2009.07.005. [DOI] [PubMed] [Google Scholar]
- 30.Sass A, Rutters H, Cypionka H, Sass H. 2002. Desulfobulbus mediterraneus sp. nov., a sulfate-reducing bacterium growing on mono- and disaccharides. Arch Microbiol 177:468–474. doi: 10.1007/s00203-002-0415-5. [DOI] [PubMed] [Google Scholar]
- 31.Smith LDS. 1975. The pathogenic anaerobic bacteria. Charles C Thomas, Springfield, IL. [Google Scholar]
- 32.Li J, McClane BA. 2006. Further comparison of temperature effects on growth and survival of Clostridium perfringens type A isolates carrying a chromosomal or plasmid-borne enterotoxin gene. Appl Environ Microbiol 72:4561–4568. doi: 10.1128/AEM.00177-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Price KE, Camilli A. 2009. Pneumolysin localizes to the cell wall of Streptococcus pneumoniae. J Bacteriol 191:2163–2168. doi: 10.1128/JB.01489-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.McPhillips TM, McPhillips SE, Chiu HJ, Cohen AE, Deacon AM, Ellis PJ, Garman E, Gonzalez A, Sauter NK, Phizackerley RP, Soltis SM, Kuhn P. 2002. Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines. J Synchrotron Radiat 9:401–406. doi: 10.1107/S0909049502015170. [DOI] [PubMed] [Google Scholar]
- 35.Kabsch W. 2010. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr D Biol Crystallogr 66:133–144. doi: 10.1107/S0907444909047374. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Collaborative Computational Project Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 50:760–763. doi: 10.1107/S0907444994003112. [DOI] [PubMed] [Google Scholar]
- 37.Panjikar S, Parthasarathy V, Lamzin VS, Weiss MS, Tucker PA. 2005. Auto-rickshaw: an automated crystal structure determination platform as an efficient tool for the validation of an X-ray diffraction experiment. Acta Crystallogr D Biol Crystallogr 61:449–457. doi: 10.1107/S0907444905001307. [DOI] [PubMed] [Google Scholar]
- 38.Panjikar S, Parthasarathy V, Lamzin VS, Weiss MS, Tucker PA. 2009. On the combination of molecular replacement and single-wavelength anomalous diffraction phasing for automated structure determination. Acta Crystallogr D Biol Crystallogr 65:1089–1097. doi: 10.1107/S0907444909029643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kale L, Schulten K. 2005. Scalable molecular dynamics with NAMD. J Comput Chem 26:1781–1802. doi: 10.1002/jcc.20289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.van Pee K, Neuhaus A, D’Imprima E, Mills DJ, Kuhlbrandt W, Yildiz O. 2017. CryoEM structures of membrane pore and prepore complex reveal cytolytic mechanism of pneumolysin. Elife 6:e23644. doi: 10.7554/eLife.23644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Czajkowsky DM, Hotze EM, Shao Z, Tweten RK. 2004. Vertical collapse of a cytolysin prepore moves its transmembrane β-hairpins to the membrane. EMBO J 23:3206–3215. doi: 10.1038/sj.emboj.7600350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Ramachandran R, Tweten RK, Johnson AE. 2005. The domains of a cholesterol-dependent cytolysin undergo a major FRET-detected rearrangement during pore formation. Proc Natl Acad Sci U S A 102:7139–7144. doi: 10.1073/pnas.0500556102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. doi: 10.1002/jcc.20084. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.